Summary by Moomoo AI
On April 10, 2024, Shah Capital Management, Inc., Shah Capital Opportunity Fund LP, and Himanshu H. Shah, collectively referred to as the Reporting Persons, filed an amended Schedule 13D/A with the SEC regarding their investment in Novavax, Inc. The Reporting Persons now collectively own 6.66%, 6.21%, and 6.70% of Novavax's outstanding shares, respectively. The shares were acquired for investment purposes in the ordinary course of business, with no current plans to influence or control the company's operations. The Reporting Persons may engage in discussions with Novavax's management, other shareholders, or third parties regarding potential changes in operations, strategy, or corporate structure. The Reporting Persons have also entered into a Joint Filing Agreement, indicating their collaborative approach to the filing. The filing emphasizes that, except for the shares directly owned by Himanshu H. Shah, all shares were purchased using the investment capital of the Reporting Persons through open market transactions.